GlassScriptPhysician profile
Chris Mark Loftis
NPI 1447602339
$78,311.29
in general payments reported to CMS, 2019-2025
18 companies · $18K in 2025
The $18K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,380 · 2020: $722 · 2021: $7,553 · 2022: $23K · 2023: $12K · 2024: $16K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $6,098 · Food and Beverage: $3,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,513.45 |
| Travel and Lodging | $6,097.70 |
| Food and Beverage | $3,504.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $40,676.14 | 2019-2025 | Inhance, Velys |
| Arthrex, INC. | $11,408.68 | 2021-2025 | |
| Smith+Nephew, INC. | $10,244.42 | 2021-2022 | |
| Encore Medical, LP | $5,321.10 | 2021-2022 | |
| Depuy Synthes Sales INC. | $2,837.41 | 2021-2025 | Inhance, Na, Velys |
| Elite Orthopedics, LLC | $1,980.00 | 2019-2021 | |
| Stryker Corporation | $1,349.18 | 2019-2025 | Blueprint Patient Specific Instrumentation, Reunion, Inspace |
| Alpha Orthopedic Systems | $1,297.38 | 2022-2023 | |
| Medinc of Texas | $1,233.42 | 2022 | |
| Music City Medical Technologies, LLC | $906.72 | 2024-2025 | |
| Depuy Synthes Products, INC. | $675.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $203.16 | 2019-2021 | |
| Seaspine Orthopedics Corporation | $84.01 | 2019 | |
| Anika Therapeutics, INC. | $29.11 | 2024 | X-Twist |
| Skeletal Dynamics INC | $20.00 | 2025 | Align, Geminus, Ijs |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17.71 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.27 | 2023 | Seglentis |
| Boston Scientific Corporation | $13.58 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Loftis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.